Access Programs
214 programsIraq Exceptional Drug Access Program
Framework: MOH Iraq Drug Regulations
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Israel Compassionate Use Program
Framework: Pharmacists Ordinance Section 27
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use30d
Italy Compassionate Use Program
Framework: Decreto Ministeriale 7 settembre 2017
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use45d
Jamaica Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Japan Compassionate Use Program
Framework: Pharmaceutical and Medical Device Act
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use60d
Japan Compassionate Use System
Framework: Pharmaceutical Affairs Law Article 80
Serious life-threatening disease with no approved treatment in Japan; drug under development or approved overseas; clinical trial participation not possible; physician determines medical necessity; institutional review board approval
Compassionate Use45d
Jordan Compassionate Use Program
Framework: Jordanian Drug and Food Law No. 80 of 2001
Patient with serious or life-threatening condition, no registered alternative available
Compassionate Use21d
Kazakhstan Named Patient Program
Framework: Kazakhstan Law on Medications
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Kenya Named Patient Program
Framework: Pharmacy and Poisons Act Cap 244
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program21d
Kiribati Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Korea Expanded Access Program
Framework: Pharmaceutical Affairs Act
Patient with serious or life-threatening condition, no registered alternative available
Expanded Access30d
Kuwait Named Patient Supply
Framework: KFDA Drug Import Regulations
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Kyrgyzstan Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Laos Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Lebanon Named Patient Program
Framework: MOH Lebanon Drug Regulations
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program30d
Lesotho Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Liberia Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Libya Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Madagascar Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Malawi Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Malaysia Special Access Scheme
Framework: Malaysian Drug Control Authority Act 1984
Patient with serious or life-threatening condition, no registered alternative available
Special Access14d
Maldives Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Mali Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d
Marshall Islands Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program60d
Mauritania Named Patient Program
Patient with serious or life-threatening condition, no registered alternative available
Named Patient Program45d